Moleculin kicks off phase 1b/2 annamycin cancer trial
May 25 2021 - 8:14AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Moleculin Biotech (NASDAQ:MBRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Moleculin Biotech (NASDAQ:MBRX)
Historical Stock Chart
From Apr 2023 to Apr 2024